Presentations

Peer Refereed Presentations with Published Abstracts

1. Dusetzina S, Farley JF, Hansen RA. Relationship between State Medicaid Copayment Policies and Prescription Drug Utilization and Expenditures. Podium presentation at the Southern Pharmacy Administration Conference, Little Rock, AR, June 15-17, 2007.

2. Devine JW, Hadsall RS, Farley JF.  Extending Matching Estimators of Causal Effects to Consider Unobserved Variable Bias: An Application of Sensitivity Analysis.  Poster presentation at the Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Philadelphia, PA, May 20-24, 2006.

3. Farley JF. Payment and Utilization Effects of a Step Therapy Prior Authorization Program for Atypical Antipsychotic Medications.  Podium presentation at the Annual Meeting of the American Pharmacists Association-Academy of Pharmaceutical Research and Science-Economic, Social and Administrative Sciences Section, San Francisco, CA, March 17 to 21, 2006.

4. Farley JF.  A Comparison of the Elixhauser and Charlson Indices to Control for Confounding in Health Outcomes Studies.  Poster presentation at the Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Washington, D.C. May 15 to 18, 2005.

5. Devine JW, Farley JF, Hadsall R. Distribution and Determinants of Prescription Medication Use Among Individuals with Headache in the United States.  Podium presentation at the Annual Meeting of the American Pharmacists Association-Academy of Pharmaceutical Research and Science-Economic, Social and Administrative Sciences Section, Orlando, Fl, April 1 to 5, 2005.

6. Farley JF, Cline RR, Gupta K.  An Examination of Racial Variations in Prescribing of Antiresorptive Medications using the 2000 Medical Expenditure Panel Survey (MEPS). Podium presentation at the Annual Meeting of the American Pharmacists Association-Academy of Pharmaceutical Research and Science-Economic, Social and Administrative Sciences Section, Orlando, Fl, April 1 to 5, 2005.

7. Farley JF, Cline RR, Schommer JC.  Prior Authorizations and Potential Spillover Effects.  Poster presentation at the Midwest Pharmacy Administration Conference, Purdue University, July 29 to August 1 2004.

8. Cline RR, Farley JF, Hansen RA, Schommer JC.  Osteoporosis beliefs and antiresorptive medication use.   Podium presentation at the Annual Meeting of the American Pharmacists Association-Academy of Pharmaceutical Research and Science-Economic, Social and Administrative Sciences Section, Seattle, WA, March 26 to 30, 2004.

9. Farley JF, Cline RR, Hansen RA. Resorptive drug use patterns among Minnesota females: results of a statewide survey.  Poster presentation at the Annual Meeting of the American Pharmacists Association-Academy of Pharmaceutical Research and Science-Economic, Social and Administrative Sciences Section Seattle, WA, March 26 to 30, 2004.

10. Farley JF, Hadsall R, Novak J. Perceptions and reporting of errors in community pharmacy practice.  Poster presentation at the Annual Meeting of the American Pharmacists Association-Academy of Pharmaceutical Research and Science-Economic, Social and Administrative Sciences Section, New Orleans, LA, March 28 to April 1, 2003.

Non-Peer Refereed Presentations

Invited Presentations

1. “Follow-On Biologics: Policy Implications … The Next Generics?”  Presented to Fellows of the American Pharmacists Association at the “Fellow Think Tank” San Francisco, CA, March 20th, 2006.

2. “Racial variation in antiresorptive medications use: results from the 2000 Medical Expenditure Panel Survey (MEPS)” Presented to the American College of Clinical Pharmacy at the symposium entitled “Research conducted with publicly available, population-based surveys: Learn from the experts” Memphis, TN, April 24, 2007.